Discriminative stimulus properties of eltoprazine

Life Sciences

Volumn 61, Issue 1, 1997, Pages 11-19

  Gommans, Jan ^a,b   Hijzen, Theo H ^a,b   Maes, Robert A ^b   Olivier, Berend ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

( ) alprenolol; 5 HT(1A) receptor; 5 HT(1B) receptor; Anpirtoline; Drug discrimination; Eltoprazine; GR127935; WAY 100635

Indexed keywords

1 (2 METHOXYPHENYL) 4 (4 PHTHALIMIDOBUTYL)PIPERAZINE; 5 METHOXY 3 (1,2,3,6 TETRAHYDRO 4 PYRIDYL) 1H INDOLE; ALPRENOLOL; ANPIRTOLINE; ELTOPRAZINE; FLESINOXAN; METITEPINE; N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL)[1,1' BIPHENYL] 4 CARBOXAMIDE; ONDANSETRON; PINDOLOL; PROPRANOLOL; SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DRUG DISCRIMINATION; DRUG EFFECT; MUSCLE RELAXATION; NONHUMAN; RAT; RECEPTOR AFFINITY; SEDATION; SEROTONINERGIC NERVE CELL; STIMULUS RESPONSE;

ANIMALS; CONDITIONING, OPERANT; DISCRIMINATION (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; PIPERAZINES; RATS; RATS, WISTAR; SEROTONIN AGONISTS;

ANIMALIA;

EID: 0030809259     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(97)00352-4     Document Type: Article

References (24)

1. B. OLIVIER, J. MOS, M. RAGHOEBAR, P DE KONING, M. MAK, Progr. Drug Res. 42 167-308 (1994).
2. P. CHOPIN, C. MORET, M. BRILEY, Pharmacol. Ther. 62 385-405 (1994)
3. D.J. SANGER, H. SCHOEMAKER, Psychopharmacology 108 85-92 (1992).
4. C.E. YBEMA, J.L. SLANGEN, B. OLIVIER, J. MOS, Pharmacol. Biochem. Behav. 35 781-784 (1990).
5. C.E. YBEMA, J.L. SLANGEN, B. OLIVIER, J. MOS, Behav. Pharmacol. 4 610-624 (1993).
6. K.A. CUNNINGHAM, P.M. CALLAHAN, J.B. APPEL, Psychopharmacology 90 193-197 (1986).
7. C.R. GARDNER, Pharmacol. Biochem. Behav. 33 761-764 (1989).
8. M.D.B. SWEDBERG, H.E. SHANNON, B. NICKEL, S.R. GOLDBERG, J. Pharmacol. Exp. Ther. 263 1015-1022 (1992).
9. W. KOEK, F. C. COLPAERT, Behavioural Pharmacology of 5-HT, P. Bevan, A.R. Cools, T. Archer (eds.), 407-424, Lawrence Erlbaum Associates, New Jersey (1989).
10. C.E. YBEMA, J.L. SLANGEN, B. OLIVIER, J. MOS, J. Pharmacol. Exp. Ther. 260 1045-1052 (1992a).
11. C.E. YBEMA, J.L. SLANGEN, B. OLIVIER, Flesinoxan and Eltoprazine, PhD thesis, Utrecht University, 107-118, (1992b).
12. E. SCHLICKER, U. WERNAR, M. HAMON, H. GOZLAN, B. NICKEL, I. SZELENYI, M. GOTHERT, Br. J. Pharmacol. 105 732-738 (1992).
13. D. HOYER, J. Rec. Res. 8 59-81 (1988).
14. P. SCHOEFFTER, D. HOYER, Naunyn-Schmiedeberg's Arch. Pharmacol. 339 675-683 (1989).
15. J. GOMMANS, T.H. HIJZEN, R.A.A. MAES, J. MOS, B. OLIVIER, Eur. J. Pharmacol. 284 135-140 (1995).
16. M.J. PIESLA, K.L. MARQUIS, Soc. Neurosci. Abstr. 20 377 (1994).
17. A. FLETCHER, E.A. FORSTER, D.J. BILL, G. BROWN, I.A. CLIFFE, J.E. HARTLEY, D.E. JONES, A. McLENACHAN, K.J. STANHOPE, D.J.P. CRITCHLEY, K.J. CHILDS, V.C. MIDDLEFELL, L. LANFUMEY, R. CORRADETTI, A.M. LAPORTE, H. GOZLAN, M. HAMON, C.T. DOURISH, Behav. Brain Res. 73 337-353 (1996).
18. J. GOMMANS, T.H. HIJZEN, R.A.A. MAES, B. OLIVIER,), Soc. Neurosci Abstr. 21 195 (1995).
19. W. KOEK, F.C. COLPAERT, J. VIGNON, J. Pharmacol. Exp. Ther. 264 746-756 (1993).
20. M. SKINGLE, G. A. HIGGINS, W. FENIUK, J. Psychopharmacol. 8 14-21 (1994).
21. M. SKINGLE, D.I.C. SCOPES, W. FENIUK, H.E. CONNER, M.C. CARTER, J.W. CLITHEROW, M.B. TYERS, Br J Pharmacol. 110 9P (1993)
22. P.J. PAUWELS, C. PALMIER, Eur. J. Pharmacol. 290 95-103 (1995).
23. H. FRANCES, F. KHIDICHIAN, C. MONTER, Pharmacol. Biochem. Behav. 35 841-845 (1990).
24. J.-A.W. WHITE, I.P. STOLERMAN, Behav. Pharmacol. 5 351-355 (1994).